Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A meta-analysis of add-on use of spironolactone in patients with resistant hypertension
Di Zhao, Hui Liu, Pingshuan Dong, et al.
International Journal of Cardiology (2016) Vol. 233, pp. 113-117
Closed Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams, Giuseppe Mancia, Wilko Spiering, et al.
European Heart Journal (2018) Vol. 39, Iss. 33, pp. 3021-3104
Open Access | Times Cited: 8813
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams, Giuseppe Mancia, Wilko Spiering, et al.
Journal of Hypertension (2018) Vol. 36, Iss. 10, pp. 1953-2041
Open Access | Times Cited: 2578
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Satoshi Umemura, Hisatomi Arima, Shuji Arima, et al.
Hypertension Research (2019) Vol. 42, Iss. 9, pp. 1235-1481
Open Access | Times Cited: 1536
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association
Robert M. Carey, David A. Calhoun, George L. Bakris, et al.
Hypertension (2018) Vol. 72, Iss. 5
Open Access | Times Cited: 851
Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children
Doreen M. Rabi, Kerry A. McBrien, Ruth Sapir‐Pichhadze, et al.
Canadian Journal of Cardiology (2020) Vol. 36, Iss. 5, pp. 596-624
Closed Access | Times Cited: 480
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
John W. McEvoy, Cian P. McCarthy, Rosa María Bruno, et al.
European Heart Journal (2024)
Closed Access | Times Cited: 322
Prevalence of Apparent Treatment-Resistant Hypertension in the United States
Robert M. Carey, Swati Sakhuja, David A. Calhoun, et al.
Hypertension (2019) Vol. 73, Iss. 2, pp. 424-431
Open Access | Times Cited: 172
Hypertension management in patients with cardiovascular comorbidities
Lucas Lauder, Felix Mahfoud, Michel Azizi, et al.
European Heart Journal (2022) Vol. 44, Iss. 23, pp. 2066-2077
Open Access | Times Cited: 101
2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.
Tzung‐Dau Wang, Chern‐En Chiang, Ting‐Hsing Chao, et al.
PubMed (2022) Vol. 38, Iss. 3, pp. 225-325
Closed Access | Times Cited: 90
Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans
Jordana B. Cohen, Debbie L. Cohen, Daniel S. Herman, et al.
Annals of Internal Medicine (2020) Vol. 174, Iss. 3, pp. 289-297
Open Access | Times Cited: 119
Management of hyperkalemia in patients with kidney disease: a position paper endorsed by the Italian Society of Nephrology
Stefano Bianchi, Filippo Aucella, Luca De Nicola, et al.
Journal of Nephrology (2019) Vol. 32, Iss. 4, pp. 499-516
Open Access | Times Cited: 95
2018 ESC/ESH Guidelines for the management of arterial hypertension

Revista Española de Cardiología (2019) Vol. 72, Iss. 2, pp. 160.e1-160.e78
Open Access | Times Cited: 48
Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options
Enrique Morales, Paolo Cravedi, Joaquín Manrique
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 28
Eplerenone Versus Spironolactone in Resistant Hypertension: an Efficacy and/or Cost or Just a Men’s Issue?
Antonis A. Manolis, Theodora A. Manolis, Helen Melita, et al.
Current Hypertension Reports (2019) Vol. 21, Iss. 3
Closed Access | Times Cited: 34
Resistant/Refractory Hypertension and Sleep Apnoea: Current Knowledge and Future Challenges
Grace Oscullo, Gerard Torres, Francisco Campos‐Rodríguez, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 11, pp. 1872-1872
Open Access | Times Cited: 31
Рекомендації Європейського товариства кардіологів ESC 2024 з лікування підвищеного артеріального тиску та гіпертензії
John W. McEvoy, Cian P. McCarthy, Sofie Brouwers, et al.
HYPERTENSION (2025) Vol. 17, Iss. 4, pp. 29-168
Open Access
Emerging Pharmacological Approaches for the Treatment of Arterial Hypertension
Francesca Schinzari, Rossella Montenero, Carmine Cardillo, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 790-790
Open Access
Clinical efficacy and safety of spironolactone in patients with resistant hypertension
Cong Chen, Xueying Zhu, Dong Li, et al.
Medicine (2020) Vol. 99, Iss. 34, pp. e21694-e21694
Open Access | Times Cited: 26
Systematic Review Article: New Drug Strategies for Treating Resistant Hypertension—the Importance of a Mechanistic, Personalized Approach
Giulia Nardoianni, Barbara Pala, Alessandra Scoccia, et al.
High Blood Pressure & Cardiovascular Prevention (2024) Vol. 31, Iss. 2, pp. 99-112
Open Access | Times Cited: 3
Efficacy of pharmacological and interventional treatment for resistant hypertension: a network meta-analysis
Zhejia Tian, Clara Vollmer Barbosa, Hannah Lang, et al.
Cardiovascular Research (2023) Vol. 120, Iss. 1, pp. 108-119
Open Access | Times Cited: 7
Recent advances in understanding and managing resistant/refractory hypertension
Michael Doumas, Κonstantinos Imprialos, Manolis S. Kallistratos, et al.
F1000Research (2020) Vol. 9, pp. 169-169
Open Access | Times Cited: 19
Esaxerenone: blood pressure reduction and cardiorenal protection without reflex sympathetic activation in salt-loaded stroke-prone spontaneously hypertensive rats
Shota Ikeda, Keisuke Shinohara, Soichiro Kashihara, et al.
Hypertension Research (2024) Vol. 47, Iss. 8, pp. 2133-2143
Closed Access | Times Cited: 2
Effect of mineralocorticoid antagonists on blood pressure lowering
George Bazoukis, Costas Thomopoulos, Costas Tsioufis
Journal of Hypertension (2018) Vol. 36, Iss. 5, pp. 987-994
Closed Access | Times Cited: 20
Thiazide diuretics are back in CKD: the case of chlorthalidone
Roberto Minutolo, Luca De Nicola, Francesca Mallamaci, et al.
Clinical Kidney Journal (2022) Vol. 16, Iss. 1, pp. 41-51
Open Access | Times Cited: 11
Molecular pharmacology of mineralocorticoid receptor antagonists: The role of co-regulators
Duygu Koca, Achim Lother
Steroids (2023) Vol. 199, pp. 109291-109291
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top